Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key companies are working in the Respiratory Syncytial Virus (RSV) therapeutics landscape. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. The Respiratory Syncytial Virus (RSV) Market Size is anticipated to increase […]
